205 related articles for article (PubMed ID: 24886852)
21. How Can Geographical Information Systems and Spatial Analysis Inform a Response to Prescription Opioid Misuse? A Discussion in the Context of Existing Literature.
Mazumdar S; Mcrae IS; Islam MM
Curr Drug Abuse Rev; 2015; 8(2):104-10. PubMed ID: 26452451
[TBL] [Abstract][Full Text] [Related]
22. Pharmaceutical opioid use among oral and intravenous users in Australia: A qualitative comparative study.
Dertadian G; Iversen J; Dixon TC; Sotiropoulos K; Maher L
Int J Drug Policy; 2017 Mar; 41():51-58. PubMed ID: 28107670
[TBL] [Abstract][Full Text] [Related]
23. Treatment of prescription opioid disorders in Canada: looking at the 'other epidemic'?
Fischer B; Kurdyak P; Goldner E; Tyndall M; Rehm J
Subst Abuse Treat Prev Policy; 2016 Mar; 11():12. PubMed ID: 26952717
[TBL] [Abstract][Full Text] [Related]
24. The Misuse of Prescription Opioids: A Threat for Europe?
van Amsterdam J; van den Brink W
Curr Drug Abuse Rev; 2015; 8(1):3-14. PubMed ID: 26084418
[TBL] [Abstract][Full Text] [Related]
25. The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis?
Fischer B; Pang M; Jones W
Subst Abuse Treat Prev Policy; 2020 Feb; 15(1):14. PubMed ID: 32066470
[TBL] [Abstract][Full Text] [Related]
26. Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009.
Fischer B; Nakamura N; Rush B; Rehm J; Urbanoski K
Drug Alcohol Depend; 2010 Jun; 109(1-3):257-60. PubMed ID: 20197216
[TBL] [Abstract][Full Text] [Related]
27. Prescription opioids, abuse and public health in Canada: is fentanyl the new centre of the opioid crisis?
Fischer B; Russell C; Murphy Y; Kurdyak P
Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1334-6. PubMed ID: 26502744
[No Abstract] [Full Text] [Related]
28. Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000.
Fischer B; Murphy Y; Rudzinski K; MacPherson D
Int J Drug Policy; 2016 Jan; 27():23-35. PubMed ID: 26359046
[TBL] [Abstract][Full Text] [Related]
29. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011.
Fischer B; Jones W; Urbanoski K; Skinner R; Rehm J
Drug Alcohol Rev; 2014 Jan; 33(1):19-26. PubMed ID: 24261474
[TBL] [Abstract][Full Text] [Related]
30. Non-medical prescription opioid use among youth: Gaining perspective from decades of previous drug use epidemics.
Cheng T; DeBeck K; Small W
Int J Drug Policy; 2016 Jan; 27():184-5. PubMed ID: 26205675
[No Abstract] [Full Text] [Related]
31. Opioid Misuse Trends in Treatment Seeking Populations: Revised Prescription Opioid Policy and Temporally Corresponding Changes.
Hoffman LA; Lewis B; Nixon SJ
Subst Use Misuse; 2017 Dec; 52(14):1850-1858. PubMed ID: 29064735
[TBL] [Abstract][Full Text] [Related]
32. A gender-based analysis of nonmedical prescription opioid use among people who use illicit drugs.
Cheng T; Nosova E; Small W; Hogg RS; Hayashi K; DeBeck K
Addict Behav; 2019 Oct; 97():42-48. PubMed ID: 31146150
[TBL] [Abstract][Full Text] [Related]
33. Nonmedical prescription opioid use and illegal drug use: initiation trajectory and related risks among people who use illegal drugs in Vancouver, Canada.
Cheng T; Small W; Nosova E; Hogg B; Hayashi K; Kerr T; DeBeck K
BMC Res Notes; 2018 Jan; 11(1):35. PubMed ID: 29338770
[TBL] [Abstract][Full Text] [Related]
34. Variations in prescription opioids and related harms: a key to understanding and effective policy.
Samet JH; Tsui JI
Addiction; 2014 Feb; 109(2):183-5. PubMed ID: 24422611
[No Abstract] [Full Text] [Related]
35. Chronic pain and opioid misuse: a review of reviews.
Voon P; Karamouzian M; Kerr T
Subst Abuse Treat Prev Policy; 2017 Aug; 12(1):36. PubMed ID: 28810899
[TBL] [Abstract][Full Text] [Related]
36. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada.
Johnson S; MacDonald SF; Cheverie M; Myrick C; Fischer B
Drug Alcohol Depend; 2012 Jul; 124(1-2):172-6. PubMed ID: 22265193
[TBL] [Abstract][Full Text] [Related]
38. The opioid crisis in Canada: a national perspective.
Belzak L; Halverson J
Health Promot Chronic Dis Prev Can; 2018 Jun; 38(6):224-233. PubMed ID: 29911818
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada.
Fischer B; Ialomiteanu A; Boak A; Adlaf E; Rehm J; Mann RE
Drug Alcohol Rev; 2013 May; 32(3):276-87. PubMed ID: 23305232
[TBL] [Abstract][Full Text] [Related]
40. Health harms of non-medical prescription opioid use: A systematic review.
Werb D; Scheim AI; Soipe A; Aeby S; Rammohan I; Fischer B; Hadland SE; Marshall BDL
Drug Alcohol Rev; 2022 May; 41(4):941-952. PubMed ID: 35437841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
